Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus

Brain-reactive autoantibodies in neuropsychiatric systemic lupus erythematosus

IntroductionThe pathogenesis of neuropsychiatric systemic lupus erythematosus (NPSLE) is widely unknown, and the role of autoantibodies is still undetermined.MethodsTo identify brain-reactive autoantibodies possibly related to NPSLE, immunofluorescence (IF) and transmission electron microscopy (TEM)...

Full description

Bibliographic Details
Main Authors:	Cristina Cocco, Elias Manca, Giulia Corda, Maria Maddalena Angioni, Barbara Noli, Mattia Congia, Francesco Loy, Michela Isola, Elisabetta Chessa, Alberto Floris, Lorena Lorefice, Luca Saba, Alessandro Mathieu, Gian Luca Ferri, Alberto Cauli, Matteo Piga
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-06-01
Series:	Frontiers in Immunology
Subjects:	systemic lupus erythematosus neuropsychiatric syndromes autoantibodies brain neurons immunofluorescence
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1157149/full

Similar Items

Targeted Therapies in Axial Psoriatic Arthritis
by: Alberto Floris, et al.
Published: (2021-06-01)

Molecular profiling of clinical remission in psoriatic arthritis reveals dysregulation of FOS and CCDC50 genes: a gene expression study
by: Maria Maddalena Angioni, et al.
Published: (2023-10-01)

Severe neuropsychiatric systemic lupus erythematosus successfully treated with rituximab: an alternative to standard of care
by: Chessa E, et al.
Published: (2017-09-01)

The role of Anti-PAD4, Anti-CarP, and Anti-RA33 antibodies combined with RF and ACPA in predicting abatacept response in rheumatoid arthritis
by: Alberto Floris, et al.
Published: (2025-01-01)

Demyelinating syndrome in SLE: review of different disease subtypes and report of a case series
by: E. Chessa, et al.
Published: (2017-12-01)

Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus
by: Matteo Piga, et al.
Published: (2017-11-01)

Effect of anti-P ribosomal and anti-NR2 antibodies on depression and cognitive processes in SLE: an integrated clinical and functional MRI study
by: Alberto Cauli, et al.
Published: (2023-11-01)

Gene Expression Profiling of Monozygotic Twins Affected by Psoriatic Arthritis
by: Angioni MM, et al.
Published: (2021-03-01)

Protective Effects of Hydroxychloroquine against Accelerated Atherosclerosis in Systemic Lupus Erythematosus
by: Alberto Floris, et al.
Published: (2018-01-01)

Assessment Of Circulating Endothelial Cells And Their Progenitors As Potential Biomarkers Of Disease Activity And Damage Accrual In Behçet’s Syndrome
by: Floris A, et al.
Published: (2019-10-01)

S14.1 The effect of anti-ribosomal-p and anti-dweys antibodies on depression and behavioral cognitive processes in systemic lupus erythematosus : an integrated clinical and functional MRI study
by: A Cauli, et al.
Published: (2022-10-01)

Whole-Body MRI in Rheumatology: Major Advances and Future Perspectives
by: Luca Deplano, et al.
Published: (2021-09-01)

Long-Term Caregiving Impact and Self-Care Strategies in Family Caregivers of People with Neuropsychiatric Disorders: A Mixed-Method Study
by: Vanessa Sánchez-Martínez, et al.
Published: (2024-11-01)

Current perspective on the role of the interleukin-23/interleukin-17 axis in inflammation and disease (chronic arthritis and psoriasis)
by: Cauli A, et al.
Published: (2015-10-01)

Breastfeeding in Pediatric Acute-Onset Neuropsychiatric Syndrome: An Italian Observational Study
by: Manuel Murciano, et al.
Published: (2021-07-01)

Attribution of Neuropsychiatric Manifestations to Systemic Lupus Erythematosus
by: Alessandra Bortoluzzi, et al.
Published: (2018-03-01)

Letter to Editor: Neuropsychiatric Consequences of Deep Brain Stimulation in Patients with Chronic Movement Disorders
by: Seyed Kazem Malakouti, et al.
Published: (2016-07-01)

The Neuropsychiatric Inventory-Diary Rating Scale (NPI-Diary): A Method for Improving Stability in Assessing Neuropsychiatric Symptoms in Dementia
by: Francesca Morganti, et al.
Published: (2018-09-01)

Severity of Neuropsychiatric Symptoms in Nursing Home Residents
by: Anne-Sofie Helvik, et al.
Published: (2016-01-01)

Neuropsychiatric symptoms in Alzheimer’s disease
by: J. Vegytė, et al.
Published: (2024-02-01)

Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review
by: Matteo Vismara, et al.
Published: (2022-05-01)

Neuropsychiatric symptoms in patients with vascular dementia in mainland China
by: Jin Yan-ling, et al.
Published: (2015-01-01)

Profiling classical neuropsychiatric biomarkers across biological fluids and following continuous lumbar puncture: A guide to sample type and time
by: Gallen Triana-Baltzer, et al.
Published: (2022-05-01)

Aspects of animal models for major neuropsychiatric disorders
by: Lefter Radu, et al.
Published: (2014-01-01)

Validation Study of the Korean Version of the Brief Clinical Form of the Neuropsychiatric Inventory
by: Hee-Jin Kim, et al.
Published: (2016-06-01)

The Structures, Functions, and Roles of Class III HDACs (Sirtuins) in Neuropsychiatric Diseases
by: Robin E. Bonomi, et al.
Published: (2024-10-01)

The merits and problems of Neuropsychiatric Inventory as an assessment tool in people with dementia and other neurological disorders
by: Lai CKY
Published: (2014-07-01)

Neuropsychiatric symptoms as first manifestation of olfactory groove meningioma - importance of neuroimaging evaluation
by: I. Vaz, et al.
Published: (2021-04-01)

Reversibility of Neuropsychiatric Adverse Events after Switching to Darunavir/Cobicistat or Doravirine in Men on INSTI-Based Regimen
by: José Antonio Mata-Marín, et al.
Published: (2024-07-01)

Noteworthy perspectives on microglia in neuropsychiatric disorders
by: Hongrui Zhu, et al.
Published: (2023-10-01)

Neuropsychiatric presentations of pediatrics brain tumors
by: Praveen Khairkar, et al.
Published: (2016-12-01)

Traumatic brain injury and neuropsychiatric complications
by: Saeed Ahmed, et al.
Published: (2017-01-01)

COVID-19: Neuropsychiatric manifestations and psychopharmacology
by: Harpreet Singh Dhillon, et al.
Published: (2020-01-01)

Neuropsychiatric aspects of paediatric brain tumours
by: Praveen Khairkar, et al.
Published: (2016-12-01)

Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections (PANDAS): Myth or Reality? The State of the Art on a Controversial Disease
by: Saverio La Bella, et al.
Published: (2023-10-01)

Racial/ethnic differences in neuropsychiatric disturbances associated with incident dementia
by: Elizabeth A. Wise, et al.
Published: (2024-07-01)

Oligodendroglial Heterogeneity in Neuropsychiatric Disease
by: Sunniva M. K. Bøstrand, et al.
Published: (2021-02-01)

Neuropsychiatric Profile in Malaria: An Overview
by: Veer Bahadur Singh, et al.
Published: (2016-07-01)

Increased TRPV1 Channels and FosB Protein Expression Are Associated with Chronic Epileptic Seizures and Anxiogenic-like Behaviors in a Preclinical Model of Temporal Lobe Epilepsy
by: Willian Lazarini-Lopes, et al.
Published: (2022-02-01)

Neuropsychiatric sequelae of attempted hanging and diagnostic dilemmas
by: Jitender Aneja, et al.
Published: (2017-01-01)